Response to high dose escalation therapy with sebelipase alfa in a patient with severe infantile lysosomal acid lipase deficiency (ILALD) and further insight into this disease
Response to high dose escalation therapy with sebelipase alfa in a patient with severe infantile lysosomal acid lipase deficiency (ILALD) and further insight into this disease
Creators - without role
Moeenaldeen AlSayed
Rozeena Huma - King Faisal Specialist Hospital & Research Centre
Wijdan Ahmad - King Faisal Specialist Hospital & Research Centre
Publication Details
Molecular genetics and metabolism, Vol.120(1-2), p.S21